Sfoglia per RIVISTA
CANCER TREATMENT REVIEWS
Collezione AOU San Luigi di Orbassano
Items : 15
Optimizing diagnosis and treatment of EGFR exon 20 insertions mutant NSCLC. in Cancer treatment reviews / Cancer Treat Rev. 2022 Sep;109:102438. doi: 10.1016/j.ctrv.2022.102438. Epub 2022 Jul 18.
2022
AOU San Luigi di Orbassano
Passiglia F; Malapelle U; Normanno N; Pinto C;
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC). in Cancer treatment reviews / Cancer Treat Rev. 2022 Feb;103:102335. doi: 10.1016/j.ctrv.2021.102335. Epub 2021 Dec 31.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Novello S; Ambrogio C; Swalduz A; Santamaria D; Pradines A; Planchard D; Nadal E; Mazieres J; Mezquita L; Pisano C; Tabbò F; Ortiz-Cuaran S;
Repositioning PARP inhibitors in the treatment of thoracic malignancies. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano
Passiglia F; Reale ML; Cetoretta V; Parlagreco E; Jacobs F; Listì A; Righi L; Bironzo P; Novello S; Scagliotti GV;
Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102250. doi: 10.1016/j.ctrv.2021.102250. Epub 2021 Jun 16.
2021
AOU San Luigi di Orbassano
Parikh K; Hendriks LEL; Bironzo P; Remon J;
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon. in Cancer treatment reviews / Cancer Treat Rev. 2021 Dec;101:102308. doi: 10.1016/j.ctrv.2021.102308. Epub 2021 Oct 18.
2021
AOU San Luigi di Orbassano
Passiglia F; Bertaglia V; Reale ML; Delcuratolo MD; Tabbò F; Olmetto E; Capelletto E; Bironzo P; Novello S;
Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer. in Cancer treatment reviews / Cancer Treat Rev. 2021 Apr;95:102178. doi: 10.1016/j.ctrv.2021.102178. Epub 2021 Mar 10.
2021
AOU San Luigi di Orbassano
Passiglia F; Novello S; Pignataro D; Remon J;
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. in Cancer treatment reviews / Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7.
2019
AOU San Luigi di Orbassano
Scagliotti GV; Veccia A; Rossetti S; Rizzo M; Maines F; Kinspergher S; Di Maio M; Cavaliere C; D'aniello C; Buttigliero C; Tucci M; Caffo O; Facchini G;
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. in Cancer treatment reviews / Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Di Maio M; Scagliotti GV; Ricardi U; Ruo Redda MG; Di Stefano RF; Leone G; Zichi C; Tucci M; Allis S; Buttigliero C; Filippi AR;
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives. in Cancer treatment reviews / Cancer Treat Rev. 2018 Nov;70:67-74. doi: 10.1016/j.ctrv.2018.08.005. Epub 2018 Aug 11.
2018
AOU San Luigi di Orbassano
Mosillo C; Iacovelli R; Ciccarese C; Fantinel E; Bimbatti D; Brunelli M; Bisogno I; Kinspergher S; Buttigliero C; Tucci M; Caffo O; Tortora G;
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. in Cancer treatment reviews / Cancer Treat Rev. 2017 Mar;54:1-9. doi: 10.1016/j.ctrv.2017.01.002. Epub 2017 Jan 11.
2017
AOU San Luigi di Orbassano
Buttigliero C; Tucci M; Vignani F; Scagliotti GV; Di Maio M;
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2016 Mar;44:61-73. doi: 10.1016/j.ctrv.2016.02.002. Epub 2016 Feb 12.
2016
AOU San Luigi di Orbassano
Vignani F; Bertaglia V; Buttigliero C; Tucci M; Scagliotti GV; Di Maio M;
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31.
2015
AOU San Luigi di Orbassano
Buttigliero C; Tucci M; Bertaglia V; Vignani F; Bironzo P; Di Maio M; Scagliotti GV;
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. in Cancer treatment reviews / Cancer Treat Rev. 2013 Dec;39(8):966-73. doi: 10.1016/j.ctrv.2013.03.003. Epub 2013 Apr 10.
2013
AOU San Luigi di Orbassano
Pia A; Vignani F; Attard G; Tucci M; Bironzo P; Scagliotti G; Arlt W; Terzolo M; Berruti A;
The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors. in Cancer treatment reviews / Cancer Treat Rev. 2012 Jun;38(4):292-302. doi: 10.1016/j.ctrv.2011.07.008. Epub 2011 Sep 9.
2012
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Radiotherapy-induced taste impairment. in Cancer treatment reviews / Cancer Treat Rev. 2006 Nov;32(7):541-7. doi: 10.1016/j.ctrv.2006.06.003. Epub 2006 Aug 2.
2006
AOU San Luigi di Orbassano
Ruo Redda MG; Allis S;